Also - Los Angeles Times
Advertisement

Also

Share via

* ICN Pharmaceuticals Inc., maker of the Rebetol hepatitis C drug, said it completed the acquisition of the 20% of Ribapharm Inc. that it didn’t already own. ICN, based in Costa Mesa, is paying $6.25 a share in cash for each outstanding share of Ribapharm.

* Pitney Bowes Inc., the world’s largest maker of postal meters and mailing equipment, said it agreed to buy DDD Co. for $49.5 million to expand its product offerings to government agencies.

Advertisement